(Q46968365)

26 December 2017

title

Population pharmacokinetics of melphalan and glutathione S-transferase polymorphisms in relation to side effects (English)

1 reference

26 December 2017

1 reference

Kühne A

1

1 reference

26 December 2017

Sezer O

2

1 reference

26 December 2017

Heider U

3

1 reference

26 December 2017

Meineke I

4

1 reference

26 December 2017

Muhlke S

5

1 reference

26 December 2017

Niere W

6

1 reference

26 December 2017

Overbeck T

7

1 reference

26 December 2017

Hohloch K

8

1 reference

26 December 2017

Trümper L

9

1 reference

26 December 2017

Brockmöller J

10

1 reference

26 December 2017

Kaiser R

11

1 reference

26 December 2017

language of work or name

English

0 references

publication date

3 October 2007

1 reference

26 December 2017

Clinical Pharmacology & Therapeutics

published in

1 reference

26 December 2017

volume

83

1 reference

26 December 2017

issue

5

1 reference

26 December 2017

page(s)

749-757

1 reference

26 December 2017

Nomenclature for human glutathione transferases

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

The treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

High-dose intravenous melphalan: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Renal clearance and protein binding of melphalan in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Population pharmacokinetics of melphalan, infused over a 24-hour period, in patients with advanced malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Reduction in glutathione content of L-PAM resistant L1210 Cells confers drug sensitivity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Dechlorination of L-phenylalanine mustard by sensitive and resistant tumor cells and its relationship to intracellular glutathione content.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Modulation of cytostatic efficacy of melphalan by glutathione: mechanisms and efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: consequences for enzyme expression and busulfan conjugation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

A sensitive high-performance liquid chromatographic assay for melphalan and its hydrolysis products in blood and plasma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liabilit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Model-based development of gemcabene, a new lipid-altering agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100336

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100336

1 reference

26 December 2017

1 reference

26 December 2017